- Home
- SPKL vs CRVO Comparison
SPKL vs CRVO Comparison
Compare SPKL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPKL
- CRVO
- Stock Information
- Founded
- SPKL 2021
- CRVO 2001
- Country
- SPKL United States
- CRVO United States
- Employees
- SPKL N/A
- CRVO N/A
- Industry
- SPKL
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- SPKL
- CRVO Health Care
- Exchange
- SPKL Nasdaq
- CRVO Nasdaq
- Market Cap
- SPKL 170.5M
- CRVO 160.4M
- IPO Year
- SPKL 2023
- CRVO N/A
- Fundamental
- Price
- SPKL $10.49
- CRVO $19.17
- Analyst Decision
- SPKL
- CRVO Strong Buy
- Analyst Count
- SPKL 0
- CRVO 4
- Target Price
- SPKL N/A
- CRVO $58.25
- AVG Volume (30 Days)
- SPKL 25.8K
- CRVO 68.8K
- Earning Date
- SPKL 01-01-0001
- CRVO 08-09-2024
- Dividend Yield
- SPKL N/A
- CRVO N/A
- EPS Growth
- SPKL N/A
- CRVO N/A
- EPS
- SPKL 0.12
- CRVO N/A
- Revenue
- SPKL N/A
- CRVO $9,653,281.00
- Revenue This Year
- SPKL N/A
- CRVO $47.04
- Revenue Next Year
- SPKL N/A
- CRVO N/A
- P/E Ratio
- SPKL $85.78
- CRVO N/A
- Revenue Growth
- SPKL N/A
- CRVO 585.67
- 52 Week Low
- SPKL $10.07
- CRVO $4.28
- 52 Week High
- SPKL $11.35
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- SPKL 73.04
- CRVO 55.34
- Support Level
- SPKL $10.45
- CRVO $14.83
- Resistance Level
- SPKL $10.46
- CRVO $17.43
- Average True Range (ATR)
- SPKL 0.00
- CRVO 1.76
- MACD
- SPKL -0.00
- CRVO 0.04
- Stochastic Oscillator
- SPKL 100.00
- CRVO 73.22
About SPKL Spark I Acquisition Corp.
Spark I Acquisition Corp is a Blank check company.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.